Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOSCA: Subcutaneous Tocilizumab in Rheumatoid Arthritis
NCT02001987Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Jan 2014; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02001987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001987.